4.01
price down icon8.03%   -0.35
pre-market  Pre-mercato:  3.92   -0.09   -2.24%
loading
Precedente Chiudi:
$4.36
Aprire:
$4.35
Volume 24 ore:
3.70M
Relative Volume:
0.60
Capitalizzazione di mercato:
$1.09B
Reddito:
$8.10M
Utile/perdita netta:
$-92.72M
Rapporto P/E:
-11.23
EPS:
-0.3571
Flusso di cassa netto:
$-82.52M
1 W Prestazione:
+2.30%
1M Prestazione:
-20.59%
6M Prestazione:
+71.37%
1 anno Prestazione:
+81.45%
Intervallo 1D:
Value
$3.98
$4.35
Intervallo di 1 settimana:
Value
$3.6929
$4.495
Portata 52W:
Value
$1.05
$5.5082

Taysha Gene Therapies Inc Stock (TSHA) Company Profile

Name
Nome
Taysha Gene Therapies Inc
Name
Telefono
(214) 612-0000
Name
Indirizzo
3000 PEGASUS PARK DRIVE, DALLAS
Name
Dipendente
73
Name
Cinguettio
Name
Prossima data di guadagno
2024-11-12
Name
Ultimi documenti SEC
Name
TSHA's Discussions on Twitter

Confronta TSHA con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
TSHA
Taysha Gene Therapies Inc
4.01 1.19B 8.10M -92.72M -82.52M -0.3571
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
434.52 110.16B 11.74B 3.68B 3.34B 14.19
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
694.99 71.65B 14.25B 4.58B 3.88B 41.77
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
453.97 59.81B 3.21B 43.57M 221.36M 0.2405
Biotechnology icon
ARGX
Argen X Se Adr
891.73 54.79B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
ONC
Beone Medicines Ltd Adr
368.36 41.77B 4.98B 69.59M 525.67M 0.5197

Taysha Gene Therapies Inc Stock (TSHA) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-10-21 Iniziato Raymond James Strong Buy
2025-07-11 Iniziato BofA Securities Buy
2024-06-27 Iniziato BMO Capital Markets Outperform
2024-04-09 Iniziato Piper Sandler Overweight
2023-02-01 Downgrade Jefferies Buy → Hold
2023-01-27 Downgrade Morgan Stanley Overweight → Equal-Weight
2022-11-09 Downgrade Goldman Buy → Neutral
2022-03-09 Iniziato Robert W. Baird Outperform
2022-03-01 Iniziato Wells Fargo Overweight
2022-02-18 Iniziato SMBC Nikko Outperform
2021-12-16 Iniziato Guggenheim Buy
2021-07-16 Iniziato Needham Buy
2021-06-24 Iniziato Truist Buy
2021-06-15 Iniziato BTIG Research Buy
2021-06-09 Iniziato Wedbush Outperform
2021-06-08 Iniziato JMP Securities Mkt Outperform
2021-05-19 Iniziato Cantor Fitzgerald Overweight
2021-05-11 Ripresa Jefferies Buy
2021-02-24 Iniziato William Blair Outperform
2021-01-05 Iniziato Oppenheimer Outperform
2020-10-19 Iniziato Chardan Capital Markets Buy
2020-10-19 Iniziato Goldman Buy
2020-10-19 Iniziato Jefferies Buy
2020-10-19 Iniziato Morgan Stanley Overweight
Mostra tutto

Taysha Gene Therapies Inc Borsa (TSHA) Ultime notizie

pulisher
04:35 AM

How Taysha Gene Therapies Inc. stock benefits from strong dollarJuly 2025 Chart Watch & Risk Controlled Daily Trade Plans - newser.com

04:35 AM
pulisher
03:38 AM

Is Taysha Gene Therapies Inc. stock near bottom after declineWeekly Risk Report & Consistent Profit Alerts - newser.com

03:38 AM
pulisher
Nov 13, 2025

Using Bollinger Bands to evaluate Taysha Gene Therapies Inc.2025 Valuation Update & Trade Opportunity Analysis Reports - newser.com

Nov 13, 2025
pulisher
Nov 13, 2025

Will Taysha Gene Therapies Inc. stock recover after recent drop2025 Earnings Surprises & Fast Momentum Entry Tips - newser.com

Nov 13, 2025
pulisher
Nov 13, 2025

Taysha Gene Therapies Experiences Revision in Its Stock Evaluation Amid Mixed Performance Metrics - Markets Mojo

Nov 13, 2025
pulisher
Nov 13, 2025

Short interest data insights for Taysha Gene Therapies Inc.2025 EndofYear Setup & High Conviction Trade Alerts - newser.com

Nov 13, 2025
pulisher
Nov 12, 2025

Custom watchlist performance reports with Taysha Gene Therapies Inc.July 2025 Price Swings & High Return Trade Guides - newser.com

Nov 12, 2025
pulisher
Nov 12, 2025

Can Taysha Gene Therapies Inc. hit a new high this monthJuly 2025 Catalysts & Weekly Momentum Picks - newser.com

Nov 12, 2025
pulisher
Nov 11, 2025

Commit To Purchase Taysha Gene Therapies At $2.50, Earn 24% Using Options - Nasdaq

Nov 11, 2025
pulisher
Nov 11, 2025

Detecting support and resistance levels for Taysha Gene Therapies Inc.2025 Key Highlights & High Return Stock Watch Alerts - newser.com

Nov 11, 2025
pulisher
Nov 10, 2025

Candlestick signals on Taysha Gene Therapies Inc. stock todayBuy Signal & Accurate Entry and Exit Point Alerts - newser.com

Nov 10, 2025
pulisher
Nov 09, 2025

Will breakout in Taysha Gene Therapies Inc. lead to full recoveryPortfolio Performance Report & Technical Pattern Based Signals - newser.com

Nov 09, 2025
pulisher
Nov 09, 2025

How institutional ownership impacts Taysha Gene Therapies Inc. stockWeekly Risk Report & Free Risk Controlled Daily Trade Plans - newser.com

Nov 09, 2025
pulisher
Nov 09, 2025

Published on: 2025-11-09 05:46:32 - newser.com

Nov 09, 2025
pulisher
Nov 07, 2025

Citizens Lifts Price Target for Taysha Gene Therapies (TSHA) - Insider Monkey

Nov 07, 2025
pulisher
Nov 07, 2025

Taysha Gene Therapies Hits Day Low at $3.97 Amid Price Pressure - Markets Mojo

Nov 07, 2025
pulisher
Nov 07, 2025

Taysha Gene Therapies Inc. (TSHA) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade

Nov 07, 2025
pulisher
Nov 07, 2025

Can momentum traders help lift Taysha Gene Therapies Inc.2025 Buyback Activity & Free Safe Capital Growth Stock Tips - newser.com

Nov 07, 2025
pulisher
Nov 06, 2025

Why Taysha Gene Therapies Inc. stock is rated strong buyPortfolio Value Report & Safe Entry Momentum Tips - newser.com

Nov 06, 2025

Taysha Gene Therapies Inc Azioni (TSHA) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading

Taysha Gene Therapies Inc Azioni (TSHA) insider trading

Commercio interno Relazione Data Transazione Costo #Azioni Valore ($) #Azioni Totale
Nagendran Sukumar
President and Head of R&D
Sep 10 '25
Option Exercise
0.70
41,150
28,760
1,206,439
Nagendran Sukumar
President and Head of R&D
Sep 10 '25
Sale
3.23
200,000
646,000
1,006,439
$39.73
price up icon 0.35%
$30.24
price down icon 0.75%
$105.41
price down icon 2.63%
$103.88
price down icon 7.00%
$190.96
price down icon 1.76%
biotechnology ONC
$368.36
price down icon 2.41%
Capitalizzazione:     |  Volume (24 ore):